Skip to main content

Advanced Search

Advanced Search

Current Filters

Filter your query

Publication Types

Other

to

Grant

/

Authorization to Support Federal Policy Options to Lower Prescription Drug Prices

Grant Details

Grantee Organization
The Commonwealth Fund

Principal Investigator
Lovisa Gustafsson

Term
2/15/22 - 9/15/22

Award Amount
$350,000

Approval Year

Related Program
Controlling Health Care Costs

Topics
Prescription Drugs

Grant Details

Grantee Organization
The Commonwealth Fund

Principal Investigator
Lovisa Gustafsson

Term
2/15/22 - 9/15/22

Award Amount
$350,000

Approval Year

Related Program
Controlling Health Care Costs

Topics
Prescription Drugs

This project will inform, analyze, and assess prescription drug pricing reforms with and without enactment of the Building Back Better Act's (BBBA) drug pricing provisions. Given the uncertain legislative agenda, an authorization will provide program staff with flexibility to develop relevant, timely, and targeted projects. If new drug pricing legislation is not passed, the projects will inform administrative actions and Center for Medicare and Medicaid Innovation models, highlighting opportunities for new initiatives based on existing evidence. Likely areas of focus include how to promote greater use of the highest-value drug regimens, including those centered on generics, biosimilars, and the most cost-effective therapeutic alternatives. If the BBBA does pass, additional work will develop and/or synthesize evidence to guide implementation of the drug price negotiation and inflation rebate provisions. For all these activities, the researchers will consider how different options would affect racial equity.

Related Grants